Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 139 entries
Sorted by: Best Match Show Resources per page
Ion transfer battery: storing energy by transferring ions across liquid-liquid interfaces.

Chemical communications (Cambridge, England)

Peljo P, Bichon M, Girault HH.
PMID: 27327108
Chem Commun (Camb). 2016 Jul 28;52(63):9761-4. doi: 10.1039/c6cc04325a.

A battery utilizing the Galvani potential difference between aqueous and organic phases is demonstrated. The battery consists of two organic redox electrolytes separated by an immiscible aqueous phase. The charge is stored by transferring a salt from the aqueous...

Cite
Peljo P, Bichon M, Girault HH. Ion transfer battery: storing energy by transferring ions across liquid-liquid interfaces. Chem Commun (Camb). 2016;52(63):9761-4doi: 10.1039/c6cc04325a.
Peljo, P., Bichon, M., & Girault, H. H. (2016). Ion transfer battery: storing energy by transferring ions across liquid-liquid interfaces. Chemical communications (Cambridge, England), 52(63), 9761-4. https://doi.org/10.1039/c6cc04325a
Peljo, Pekka, et al. "Ion transfer battery: storing energy by transferring ions across liquid-liquid interfaces." Chemical communications (Cambridge, England) vol. 52,63 (2016): 9761-4. doi: https://doi.org/10.1039/c6cc04325a
Peljo P, Bichon M, Girault HH. Ion transfer battery: storing energy by transferring ions across liquid-liquid interfaces. Chem Commun (Camb). 2016 Jul 28;52(63):9761-4. doi: 10.1039/c6cc04325a. PMID: 27327108.
Copy Download .nbib Format: NLM
Bright Visible-Infrared Light Emitting Diodes Based on Hybrid Halide Perovskite with Spiro-OMeTAD as a Hole-Injecting Layer.

The journal of physical chemistry letters

Jaramillo-Quintero OA, Sanchez RS, Rincon M, Mora-Sero I.
PMID: 26263264
J Phys Chem Lett. 2015 May 21;6(10):1883-90. doi: 10.1021/acs.jpclett.5b00732. Epub 2015 May 06.

Hybrid halide perovskites that are currently intensively studied for photovoltaic applications, also present outstanding properties for light emission. Here, we report on the preparation of bright solid state light emitting diodes (LEDs) based on a solution-processed hybrid lead halide...

Cite
Jaramillo-Quintero OA, Sanchez RS, Rincon M, et al. Bright Visible-Infrared Light Emitting Diodes Based on Hybrid Halide Perovskite with Spiro-OMeTAD as a Hole-Injecting Layer. J Phys Chem Lett. 2015;6(10):1883-90doi: 10.1021/acs.jpclett.5b00732.
Jaramillo-Quintero, O. A., Sanchez, R. S., Rincon, M., & Mora-Sero, I. (2015). Bright Visible-Infrared Light Emitting Diodes Based on Hybrid Halide Perovskite with Spiro-OMeTAD as a Hole-Injecting Layer. The journal of physical chemistry letters, 6(10), 1883-90. https://doi.org/10.1021/acs.jpclett.5b00732
Jaramillo-Quintero, Oscar A, et al. "Bright Visible-Infrared Light Emitting Diodes Based on Hybrid Halide Perovskite with Spiro-OMeTAD as a Hole-Injecting Layer." The journal of physical chemistry letters vol. 6,10 (2015): 1883-90. doi: https://doi.org/10.1021/acs.jpclett.5b00732
Jaramillo-Quintero OA, Sanchez RS, Rincon M, Mora-Sero I. Bright Visible-Infrared Light Emitting Diodes Based on Hybrid Halide Perovskite with Spiro-OMeTAD as a Hole-Injecting Layer. J Phys Chem Lett. 2015 May 21;6(10):1883-90. doi: 10.1021/acs.jpclett.5b00732. Epub 2015 May 06. PMID: 26263264.
Copy Download .nbib Format: NLM
BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival.

Cancer investigation

Pagnano KB, Bendit I, Boquimpani C, De Souza CA, Miranda EC, Zalcberg I, Larripa I, Nardinelli L, Silveira RA, Fogliatto L, Spector N, Funke V, Pasquini R, Hungria V, Sérgio Chiattone C, Clementino N, Conchon M, Moiraghi EB, Lopez JL, Pavlovsky C, Pavlovsky MA, Cervera EE, Meillon LA, Simões B, Hamerschlak N, Bozzano AH, Mayta E, Cortes J, Bengió 5 On Behalf Of Latin American Leukemia Net Lalnet RM.
PMID: 26279306
Cancer Invest. 2015 Aug 17; Epub 2015 Aug 17.

This is the largest Latin American study of BCR-ABL mutations in chronic myeloid leukemia (CML) patients, resistant to imatinib (IM). In 195/467 (41%) patients, mutations were detected. The most frequent mutation was T315I (n = 31, 16%). Progression-free (PFS)...

Cite
Pagnano KB, Bendit I, Boquimpani C, et al. BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival. Cancer Invest. 2015;
Pagnano, K. B., Bendit, I., Boquimpani, C., De Souza, C. A., Miranda, E. C., Zalcberg, I., Larripa, I., Nardinelli, L., Silveira, R. A., Fogliatto, L., Spector, N., Funke, V., Pasquini, R., Hungria, V., Sérgio Chiattone, C., Clementino, N., Conchon, M., Moiraghi, E. B., Lopez, J. L., Pavlovsky, C., Pavlovsky, M. A., Cervera, E. E., Meillon, L. A., Simões, B., Hamerschlak, N., Bozzano, A. H., Mayta, E., Cortes, J., & Bengió 5 On Behalf Of Latin American Leukemia Net Lalnet, R. M. (2015). BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival. Cancer investigation, .
Pagnano, Katia Borgia Barbosa, et al. "BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival." Cancer investigation vol. (2015).
Pagnano KB, Bendit I, Boquimpani C, De Souza CA, Miranda EC, Zalcberg I, Larripa I, Nardinelli L, Silveira RA, Fogliatto L, Spector N, Funke V, Pasquini R, Hungria V, Sérgio Chiattone C, Clementino N, Conchon M, Moiraghi EB, Lopez JL, Pavlovsky C, Pavlovsky MA, Cervera EE, Meillon LA, Simões B, Hamerschlak N, Bozzano AH, Mayta E, Cortes J, Bengió 5 On Behalf Of Latin American Leukemia Net Lalnet RM. BCR-ABL Mutations in Chronic Myeloid Leukemia Treated With Tyrosine Kinase Inhibitors and Impact on Survival. Cancer Invest. 2015 Aug 17; Epub 2015 Aug 17. PMID: 26279306.
Copy Download .nbib Format: NLM
[The enigma of André Gide].

Le Progres medical

VINCHON J.
PMID: 12993829
Prog Med (Paris). 1952 May 10;80(9):218-20.

No abstract available.

Cite
VINCHON J. L'énigme d'André Gide. [The enigma of André Gide]. Prog Med (Paris). 1952;80(9):218-20
VINCHON, J. (1952). L'énigme d'André Gide. [The enigma of André Gide]. Le Progres medical, 80(9), 218-20.
VINCHON, J. "L'énigme d'André Gide." [The enigma of André Gide]. Le Progres medical vol. 80,9 (1952): 218-20.
VINCHON J. L'énigme d'André Gide. [The enigma of André Gide]. Prog Med (Paris). 1952 May 10;80(9):218-20. Undetermined. PMID: 12993829.
Copy Download .nbib Format: NLM
P53 binding sites in transposons.

Frontiers in genetics

Zemojtel T, Vingron M.
PMID: 22448161
Front Genet. 2012 Mar 20;3:40. doi: 10.3389/fgene.2012.00040. eCollection 2012.

No abstract available.

Cite
Zemojtel T, Vingron M. P53 binding sites in transposons. Front Genet. 2012;3:40doi: 10.3389/fgene.2012.00040.
Zemojtel, T., & Vingron, M. (2012). P53 binding sites in transposons. Frontiers in genetics, 340. https://doi.org/10.3389/fgene.2012.00040
Zemojtel, Tomasz, and Vingron, Martin. "P53 binding sites in transposons." Frontiers in genetics vol. 3 (2012): 40. doi: https://doi.org/10.3389/fgene.2012.00040
Zemojtel T, Vingron M. P53 binding sites in transposons. Front Genet. 2012 Mar 20;3:40. doi: 10.3389/fgene.2012.00040. eCollection 2012. PMID: 22448161; PMCID: PMC3308033.
Copy Download .nbib Format: NLM
Pediatric hydrocephalus outcomes: a review.

Fluids and barriers of the CNS

Vinchon M, Rekate H, Kulkarni AV.
PMID: 22925451
Fluids Barriers CNS. 2012 Aug 27;9(1):18. doi: 10.1186/2045-8118-9-18.

The outcome of pediatric hydrocephalus, including surgical complications, neurological sequelae and academic achievement, has been the matter of many studies. However, much uncertainty remains, regarding the very long-term and social outcome, and the determinants of complications and clinical outcome....

Cite
Vinchon M, Rekate H, Kulkarni AV. Pediatric hydrocephalus outcomes: a review. Fluids Barriers CNS. 2012;9(1):18doi: 10.1186/2045-8118-9-18.
Vinchon, M., Rekate, H., & Kulkarni, A. V. (2012). Pediatric hydrocephalus outcomes: a review. Fluids and barriers of the CNS, 9(1), 18. https://doi.org/10.1186/2045-8118-9-18
Vinchon, Matthieu, et al. "Pediatric hydrocephalus outcomes: a review." Fluids and barriers of the CNS vol. 9,1 (2012): 18. doi: https://doi.org/10.1186/2045-8118-9-18
Vinchon M, Rekate H, Kulkarni AV. Pediatric hydrocephalus outcomes: a review. Fluids Barriers CNS. 2012 Aug 27;9(1):18. doi: 10.1186/2045-8118-9-18. PMID: 22925451; PMCID: PMC3584674.
Copy Download .nbib Format: NLM
The XP-Endo Finisher for the removal of calcium hydroxide paste from root canals and from the apical third.

Journal of clinical and experimental dentistry

Hamdan R, Michetti J, Pinchon D, Diemer F, Georgelin-Gurgel M.
PMID: 28828150
J Clin Exp Dent. 2017 Jul 01;9(7):e855-e860. doi: 10.4317/jced.53962. eCollection 2017 Jul.

BACKGROUND: The aim was to compare the efficacy of the passive ultrasonic irrigation PUI and the Xp-endo Finisher (FKG-Dentaire, La-Chaux-de-Fonds, Switzerland) in removing the calcium hydroxide paste from root canals and from the apical third.MATERIAL AND METHODS: Sixty-eight root...

Cite
Hamdan R, Michetti J, Pinchon D, et al. The XP-Endo Finisher for the removal of calcium hydroxide paste from root canals and from the apical third. J Clin Exp Dent. 2017;9(7):e855-e860doi: 10.4317/jced.53962.
Hamdan, R., Michetti, J., Pinchon, D., Diemer, F., & Georgelin-Gurgel, M. (2017). The XP-Endo Finisher for the removal of calcium hydroxide paste from root canals and from the apical third. Journal of clinical and experimental dentistry, 9(7), e855-e860. https://doi.org/10.4317/jced.53962
Hamdan, Rami, et al. "The XP-Endo Finisher for the removal of calcium hydroxide paste from root canals and from the apical third." Journal of clinical and experimental dentistry vol. 9,7 (2017): e855-e860. doi: https://doi.org/10.4317/jced.53962
Hamdan R, Michetti J, Pinchon D, Diemer F, Georgelin-Gurgel M. The XP-Endo Finisher for the removal of calcium hydroxide paste from root canals and from the apical third. J Clin Exp Dent. 2017 Jul 01;9(7):e855-e860. doi: 10.4317/jced.53962. eCollection 2017 Jul. PMID: 28828150; PMCID: PMC5549582.
Copy Download .nbib Format: NLM
The Statistical Evaluation of Treatment and Outcomes in Head and Neck Squamous Cell Carcinoma Clinical Trials.

Frontiers in oncology

Fortpied C, Vinches M.
PMID: 31355146
Front Oncol. 2019 Jul 12;9:634. doi: 10.3389/fonc.2019.00634. eCollection 2019.

The purpose of this article is two-fold: to help statisticians confronted with the design, implementation and analysis of clinical trials and new to the field of head and neck cancer; but also to sensitize research physicians with the role,...

Cite
Fortpied C, Vinches M. The Statistical Evaluation of Treatment and Outcomes in Head and Neck Squamous Cell Carcinoma Clinical Trials. Front Oncol. 2019;9:634doi: 10.3389/fonc.2019.00634.
Fortpied, C., & Vinches, M. (2019). The Statistical Evaluation of Treatment and Outcomes in Head and Neck Squamous Cell Carcinoma Clinical Trials. Frontiers in oncology, 9634. https://doi.org/10.3389/fonc.2019.00634
Fortpied, Catherine, and Vinches, Marie. "The Statistical Evaluation of Treatment and Outcomes in Head and Neck Squamous Cell Carcinoma Clinical Trials." Frontiers in oncology vol. 9 (2019): 634. doi: https://doi.org/10.3389/fonc.2019.00634
Fortpied C, Vinches M. The Statistical Evaluation of Treatment and Outcomes in Head and Neck Squamous Cell Carcinoma Clinical Trials. Front Oncol. 2019 Jul 12;9:634. doi: 10.3389/fonc.2019.00634. eCollection 2019. PMID: 31355146; PMCID: PMC6640189.
Copy Download .nbib Format: NLM
Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring.

Hematology, transfusion and cell therapy

Seguro FS, Silva CMPDC, Moura CMB, Conchon M, Fogliatto L, Funke VAM, Abdo A, Macedo AVS, Santos MHHD, Saraiva JFK.
PMID: 32631809
Hematol Transfus Cell Ther. 2021 Apr-Jun;43(2):191-200. doi: 10.1016/j.htct.2020.04.009. Epub 2020 Jul 01.

This manuscript summarizes the results of the consensus meeting composed of hematologists and cardiologists to establish recommendations for the prevention and follow-up of cardiovascular (CV) risk in patients with chronic myeloid leukemia (CML) treated with BCR-ABL tyrosine kinase inhibitors...

Cite
Seguro FS, Silva CMPDC, Moura CMB, et al. Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring. Hematol Transfus Cell Ther. 2020;43(2):191-200doi: 10.1016/j.htct.2020.04.009.
Seguro, F. S., Silva, C. M. P. D. C., Moura, C. M. B., Conchon, M., Fogliatto, L., Funke, V. A. M., Abdo, A., Macedo, A. V. S., Santos, M. H. H. D., & Saraiva, J. F. K. (2021). Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring. Hematology, transfusion and cell therapy, 43(2), 191-200. https://doi.org/10.1016/j.htct.2020.04.009
Seguro, Fernanda Salles, et al. "Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring." Hematology, transfusion and cell therapy vol. 43,2 (2021): 191-200. doi: https://doi.org/10.1016/j.htct.2020.04.009
Seguro FS, Silva CMPDC, Moura CMB, Conchon M, Fogliatto L, Funke VAM, Abdo A, Macedo AVS, Santos MHHD, Saraiva JFK. Recommendations for the management of cardiovascular risk in patients with chronic myeloid leukemia on tyrosine kinase inhibitors: risk assessment, stratification, treatment and monitoring. Hematol Transfus Cell Ther. 2021 Apr-Jun;43(2):191-200. doi: 10.1016/j.htct.2020.04.009. Epub 2020 Jul 01. PMID: 32631809; PMCID: PMC8211634.
Copy Download .nbib Format: NLM
The Scleractinia (Cnidaria: Anthozoa) of Abu-Musa and Sirri Islands, Persian Gulf.

Zoological studies

Salimi PA, Ghavam Mostafavi P, Chen CA, Fatemi SMR, Pichon M.
PMID: 31966296
Zool Stud. 2018 Dec 17;57:e56. doi: 10.6620/ZS.2018.57-56. eCollection 2018.

No abstract available.

Cite
Salimi PA, Ghavam Mostafavi P, Chen CA, et al. The Scleractinia (Cnidaria: Anthozoa) of Abu-Musa and Sirri Islands, Persian Gulf. Zool Stud. 2018;57:e56doi: 10.6620/ZS.2018.57-56.
Salimi, P. A., Ghavam Mostafavi, P., Chen, C. A., Fatemi, S. M. R., & Pichon, M. (2018). The Scleractinia (Cnidaria: Anthozoa) of Abu-Musa and Sirri Islands, Persian Gulf. Zoological studies, 57e56. https://doi.org/10.6620/ZS.2018.57-56
Salimi, Parisa Alidoost, et al. "The Scleractinia (Cnidaria: Anthozoa) of Abu-Musa and Sirri Islands, Persian Gulf." Zoological studies vol. 57 (2018): e56. doi: https://doi.org/10.6620/ZS.2018.57-56
Salimi PA, Ghavam Mostafavi P, Chen CA, Fatemi SMR, Pichon M. The Scleractinia (Cnidaria: Anthozoa) of Abu-Musa and Sirri Islands, Persian Gulf. Zool Stud. 2018 Dec 17;57:e56. doi: 10.6620/ZS.2018.57-56. eCollection 2018. PMID: 31966296; PMCID: PMC6409733.
Copy Download .nbib Format: NLM
Decontamination of Intravaginal Probes Infected by Human Papillomavirus (HPV) Using UV-C Decontamination System.

Journal of clinical medicine

Pichon M, Lebail-Carval K, Billaud G, Lina B, Gaucherand P, Mekki Y.
PMID: 31653074
J Clin Med. 2019 Oct 24;8(11). doi: 10.3390/jcm8111776.

BACKGROUND: This three-step study evaluated ultraviolet-C (UV-C) efficacy against human papillomavirus (HPV) found on vaginal ultrasound probes.METHODS: The first two steps evaluated UV-C disinfection of vaginal ultrasound probes in routine condition. During the first phase, the probe (RESULTS: In...

Cite
Pichon M, Lebail-Carval K, Billaud G, et al. Decontamination of Intravaginal Probes Infected by Human Papillomavirus (HPV) Using UV-C Decontamination System. J Clin Med. 2019;8(11)doi: 10.3390/jcm8111776.
Pichon, M., Lebail-Carval, K., Billaud, G., Lina, B., Gaucherand, P., & Mekki, Y. (2019). Decontamination of Intravaginal Probes Infected by Human Papillomavirus (HPV) Using UV-C Decontamination System. Journal of clinical medicine, 8(11), . https://doi.org/10.3390/jcm8111776
Pichon, Maxime, et al. "Decontamination of Intravaginal Probes Infected by Human Papillomavirus (HPV) Using UV-C Decontamination System." Journal of clinical medicine vol. 8,11 (2019). doi: https://doi.org/10.3390/jcm8111776
Pichon M, Lebail-Carval K, Billaud G, Lina B, Gaucherand P, Mekki Y. Decontamination of Intravaginal Probes Infected by Human Papillomavirus (HPV) Using UV-C Decontamination System. J Clin Med. 2019 Oct 24;8(11). doi: 10.3390/jcm8111776. PMID: 31653074; PMCID: PMC6912769.
Copy Download .nbib Format: NLM
Genetic evidence supports a distinct lineage of American crocodile (.

PeerJ

Milián-García Y, Russello MA, Castellanos-Labarcena J, Cichon M, Kumar V, Espinosa G, Rossi N, Mazzotti F, Hekkala E, Amato G, Janke A.
PMID: 30473930
PeerJ. 2018 Nov 12;6:e5836. doi: 10.7717/peerj.5836. eCollection 2018.

Four species of true crocodile (genus

Cite
Milián-García Y, Russello MA, Castellanos-Labarcena J, et al. Genetic evidence supports a distinct lineage of American crocodile (. PeerJ. 2018;6:e5836doi: 10.7717/peerj.5836.
Milián-García, Y., Russello, M. A., Castellanos-Labarcena, J., Cichon, M., Kumar, V., Espinosa, G., Rossi, N., Mazzotti, F., Hekkala, E., Amato, G., & Janke, A. (2018). Genetic evidence supports a distinct lineage of American crocodile (. PeerJ, 6e5836. https://doi.org/10.7717/peerj.5836
Milián-García, Yoamel, et al. "Genetic evidence supports a distinct lineage of American crocodile (." PeerJ vol. 6 (2018): e5836. doi: https://doi.org/10.7717/peerj.5836
Milián-García Y, Russello MA, Castellanos-Labarcena J, Cichon M, Kumar V, Espinosa G, Rossi N, Mazzotti F, Hekkala E, Amato G, Janke A. Genetic evidence supports a distinct lineage of American crocodile (. PeerJ. 2018 Nov 12;6:e5836. doi: 10.7717/peerj.5836. eCollection 2018. PMID: 30473930; PMCID: PMC6237115.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 139 entries